HOOKIPA Pharma
(NASDAQ:HOOK)
$0.78
0.012[1.56%]
At close: Mar 1
$0.78
0[0.00%]
After Hours: 4:58PM EDT

GET A REPORT ON HOOK SENT RIGHT TO YOUR INBOX

HOOKIPA Pharma Stock (NASDAQ:HOOK), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Buy
Highest Price Target1
$19.00
Lowest Price Target1
$0.50
Consensus Price Target1
$6.58

Analyst Rating Summary1

Analyst Ratings
Sep 23
2
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Truist Securities
HC Wainwright & Co.
Morgan Stanley
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for HOOKIPA Pharma

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
01/30/2024HOOKBuy Now
HOOKIPA Pharma
$0.78541.03%RBC Capital
Brian Abrahams
$6 → $5MaintainsOutperformGet Alert
09/27/2023HOOKBuy Now
HOOKIPA Pharma
$0.78797.44%RBC Capital
Brian Abrahams
→ $7ReiteratesOutperform → OutperformGet Alert
09/06/2023HOOKBuy Now
HOOKIPA Pharma
$0.78412.82%Truist Securities
Asthika Goonewardene
→ $4ReiteratesBuy → BuyGet Alert
08/11/2023HOOKBuy Now
HOOKIPA Pharma
$0.78733.33%HC Wainwright & Co.
Arthur He
$8 → $6.5MaintainsBuyGet Alert
06/30/2023HOOKBuy Now
HOOKIPA Pharma
$0.78797.44%RBC Capital
Brian Abrahams
→ $7ReiteratesOutperform → OutperformGet Alert
06/05/2023HOOKBuy Now
HOOKIPA Pharma
$0.78188.46%Morgan Stanley
Vikram Purohit
$2 → $2.25MaintainsEqual-WeightGet Alert
05/12/2023HOOKBuy Now
HOOKIPA Pharma
$0.78925.64%HC Wainwright & Co.
Arthur He
→ $8ReiteratesBuy → BuyGet Alert
03/20/2023HOOKBuy Now
HOOKIPA Pharma
$0.78412.82%Truist Securities
Asthika Goonewardene
$11 → $4MaintainsBuyGet Alert
03/16/2023HOOKBuy Now
HOOKIPA Pharma
$0.78925.64%HC Wainwright & Co.
Arthur He
→ $8Reiterates → BuyGet Alert
12/02/2022HOOKBuy Now
HOOKIPA Pharma
$0.78-35.9%B of A Securities
Alec Stranahan
$6 → $0.5DowngradeBuy → UnderperformGet Alert
11/15/2022HOOKBuy Now
HOOKIPA Pharma
$0.78797.44%RBC Capital
Brian Abrahams
$8 → $7MaintainsOutperformGet Alert
08/23/2022HOOKBuy Now
HOOKIPA Pharma
$0.781310.26%Truist Securities
Asthika Goonewardene
$16 → $11MaintainsBuyGet Alert
08/11/2022HOOKBuy Now
HOOKIPA Pharma
$0.78284.62%SVB Leerink
Andrew Berens
$4 → $3MaintainsOutperformGet Alert
03/25/2022HOOKBuy Now
HOOKIPA Pharma
$0.781053.85%RBC Capital
Brian Abrahams
$11 → $9MaintainsOutperformGet Alert
02/17/2022HOOKBuy Now
HOOKIPA Pharma
$0.78925.64%HC Wainwright & Co.
Swayampakula Ramakanth
$15 → $8MaintainsBuyGet Alert
02/16/2022HOOKBuy Now
HOOKIPA Pharma
$0.78412.82%SVB Leerink
Andrew Berens
$3 → $4MaintainsOutperformGet Alert
11/12/2021HOOKBuy Now
HOOKIPA Pharma
$0.78669.23%Morgan Stanley
Vikram Purohit
DowngradeOverweight → Equal-WeightGet Alert
11/11/2021HOOKBuy Now
HOOKIPA Pharma
$0.781823.08%HC Wainwright & Co.
Swayampakula Ramakanth
MaintainsBuyGet Alert
11/10/2021HOOKBuy Now
HOOKIPA Pharma
$0.781182.05%SVB Leerink
Andrew Berens
MaintainsOutperformGet Alert

FAQ

Q

What is the target price for HOOKIPA Pharma (HOOK)?

A

The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by RBC Capital on January 30, 2024. The analyst firm set a price target for $5.00 expecting HOOK to rise to within 12 months (a possible 541.03% upside). 9 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HOOKIPA Pharma (HOOK)?

A

The latest analyst rating for HOOKIPA Pharma (NASDAQ: HOOK) was provided by RBC Capital, and HOOKIPA Pharma maintained their outperform rating.

Q

When is the next analyst rating going to be posted or updated for HOOKIPA Pharma (HOOK)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HOOKIPA Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HOOKIPA Pharma was filed on January 30, 2024 so you should expect the next rating to be made available sometime around January 30, 2025.

Q

Is the Analyst Rating HOOKIPA Pharma (HOOK) correct?

A

While ratings are subjective and will change, the latest HOOKIPA Pharma (HOOK) rating was a maintained with a price target of $6.00 to $5.00. The current price HOOKIPA Pharma (HOOK) is trading at is $0.78, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch